Navigation Links
Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis

KANSAS CITY, Mo.--(BUSINESS WIRE)--May 4, 2007 - New data from a randomized, double-blind study showed that a combination of COPAXONE(R) (glatiramer acetate injection) along with the oral antibiotic minocycline reduced T1 Gadolinium (Gd)-enhancing lesions of the brain by 63 percent (p=0.08) in patients with active relapsing-remitting multiple sclerosis (RRMS), as measured by magnetic resonance imaging (MRI), compared to those receiving COPAXONE(R) alone. Additionally, the nine-month study demonstrated that treatment with COPAXONE(R) in combination with minocycline reduced the number of new T2 lesions in patients by 65 percent (p=0.06). These results trended toward but did not reach statistical significance.

These data were presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, MA, April 28 - May 5, 2007.

"The results of this study indicated that further exploration of this combination is warranted, as the established effect of COPAXONE(R) on disease activity may be boosted when used in combination with minocycline for the treatment of active relapsing-remitting patients," said Luanne Metz, M.D., professor at the Department of Clinical Neuroscience of the University of Calgary, and principal investigator. "In these patients, the combination was safe and well tolerated," she added.

Minocycline is a broad-spectrum antibiotic, which is used to treat pneumonia, acne, and infections of the skin, genital and urinary systems, and the central nervous system. In a small proof-of-concept trial of 10 RRMS patients, minocycline demonstrated an 84 percent relative reduction in mean total Gd-enhancing lesions and was well tolerated, and data published in the Journal of Neuroimmunology indicated that the combination of minocycline and COPAXONE(R) decreased neuron-inflammation, axonal loss and demyelination in an animal model of MS.

"COPAXONE(R) is one of the most frequen
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Point of Care Strep Tests Speed Treatment, Lower Costs
2. Rapid HIV Testing Increases Possibility of Treatment
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Post Your Comments:
(Date:5/23/2013)... -- More than half of women diagnosed with early ... still have excellent outcomes. To educate women, Agendia, Inc. ... sources of online consumer information about breast cancer genomic ... recently diagnosed women with information sources, to help them ... "We anticipate these innovative social media campaigns will encourage ...
(Date:5/23/2013)... MONICA, Calif. , May 23, 2013 ... a program that would have required them to obtain ... today by Consumer Watchdog and Whatley Kallas LLC.  ... Diego Superior Court, alleged that Blue Cross,s mandatory mail ... patients, threatening their health and privacy. "This ...
(Date:5/23/2013)... 2013  Texas, premier physician associations today announced the ... tools they need to provide demonstrably better and more ... marketplace. "I am confident the Physician Services ... Stephen L. Brotherton , MD, president ... doctors are determined to make health care ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... 2011  Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today ... edoxaban, a direct oral once-daily Factor Xa inhibitor, significantly ... total knee or hip arthroplasty, when compared to enoxaparin. ... composite of deep vein thrombosis (DVT) and pulmonary embolism ...
... SHANGHAI, Dec. 12, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: ... medical-device research and development outsourcing company with operations in ... of its fifth Life Science and Chemistry Awards, held ... Beijing. The theme of this year,s awards ...
Cached Medicine Technology:Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 2Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 3Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 4Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 5WuXi PharmaTech Presents the 2011 Life Science and Chemistry Awards 2WuXi PharmaTech Presents the 2011 Life Science and Chemistry Awards 3
(Date:5/24/2013)... Electric™ Energy Straws, an exciting new brand of ... and will be the lead sponsor on Munoz’s Chevy #26 ... Speedway. Munoz, who is part of Andretti Autosports’ fantastic five ... race, qualifying to be named the 2013 Indy 500 Fastest ... race. , While Munoz is grabbing headlines around the ...
(Date:5/24/2013)... The point-of-care (POC) diagnostics market encompasses ... central laboratory, by other healthcare professionals, patient self-testers ... consumers. This includes products that test blood glucose ... cardiovascular disease and cancer, as well as hospital ... and emergency departments. , Critical analysis and 5-year ...
(Date:5/24/2013)... is available in German . ... "alpha-synuclein" aggregates and accumulates within neurons. Specific areas of ... and advances. The mechanism underlying this pathological progression is ... protein (or abnormal forms of it) along nerve projections ... the German Center for Neurodegenerative Diseases (DZNE) in Bonn ...
(Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... for the seventh commencement ceremony of American University ... Fisher Hall in Lincoln Center. , This was the ... master of ceremonies Dick Woodward, AUA’s Senior Vice President ... graduate processional and Dr. Reza Sanii, Associate Dean of ...
(Date:5/24/2013)... FRIDAY, May 24 (HealthDay News) -- Nearly three ... such as constipation and diarrhea, but these issues ... new study finds. Researchers from Loyola University ... bowel issues are due to physiological and hormonal ... women take during pregnancy also can play a ...
Breaking Medicine News(10 mins):Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 2Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 3Health News:Proteins in migration 2Health News:Proteins in migration 3Health News:Proteins in migration 4Health News:AUA Celebrates Seventh Annual Commencement Ceremony 2Health News:Bowel Issues Affect 3 Out of 4 Pregnant Women 2
... Your mother,s wrinkles or lack there of, ... age. In fact, a new study claims just the ... genetic make-up, certain environmental factors can add years to ... web-based version of Plastic and Reconstructive Surgery , ...
... geographic reach, expand access to patients - PRINCETON, ... CVD ), one of the world,s largest and most ... of three new clinical development offices in Kiev, Ukraine; ... the company,s global presence. Covance has been providing ...
... footage from Tucson, AZ, implicates a third Planned Parenthood ... video, UCLA student Lila Rose and her ... where Rose tells the nurse that Stollar, posing as ... nurse disregards the age difference and even cautions Stollar ...
... announces new updates to the NCCN Guidelines for ... Noteworthy additions include new recommendations on when to ... the use of PET/CT scanning for evaluative purposes, ... surgery. , FORT WASHINGTON, Pa., Feb. 3 ...
... 3 McKenna Long & Aldridge LLP (MLA) is ... of Defense for Homeland Defense, has joined the firm ... role, he will support the firm,s Life Sciences and ... Security and Disaster Planning, in addition to helping clients ...
... AMERIGROUP Corporation (NYSE: AGP ) announced today ... Chief Compliance Officer, a position charged with responsibility that ... and regulations. "John Finley,s valuable experience in government and ... out his duties at AMERIGROUP," said John E. Littel, ...
Cached Medicine News:Health News:Divorce, antidepressants, or weight gain/loss can add years to your face 2Health News:Covance Opens Three New Offices in Ukraine, Slovakia, and Israel 2Health News:Covance Opens Three New Offices in Ukraine, Slovakia, and Israel 3Health News:New Undercover Video Shows Tucson Planned Parenthood Hiding Rape of 15-Year-Old Girl 2Health News:NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines 2Health News:NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines 3Health News:NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines 4Health News:Former Assistant Secretary of Defense for Homeland Defense Joins McKenna Long & Aldridge LLP 2Health News:AMERIGROUP Names Finley Chief Compliance Officer 2
Liberty Single Piece PMMA Lens with UV Absorber....
Optical implants for the replacement of the human crystalline lens in the visual correction of aphakia....
... a sterile nonpyrogenic, transparent viscoelastic solution of ... 12 mg/ml of high molecular weight (greater ... in physiological saline. In the limit of ... cps (105 Pa s) at 25 C ...
... Plus is the preferred viscoelastic for phacoemulsification ... reliably works from the start to the ... cohesive profile of this viscoelastic is the ... associated with phacoemulsification remove only a fraction ...
Medicine Products: